|
1
|
Patel H, Dobson RJB and Newhouse SJ: A
Meta-analysis of Alzheimer's disease brain transcriptomic data. J
Alzheimers Dis. 68:1635–1656. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takousis P, Sadlon A, Schulz J, Wohlers I,
Dobricic V, Middleton L, Lill CM, Perneczky R and Bertram L:
Differential expression of microRNAs in Alzheimer's disease brain,
blood, and cerebrospinal fluid. Alzheimers Dement. 15:1468–1477.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Readhead B, Haure-Mirande JV, Funk CC,
Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann
ND, Price ND, et al: Multiscale analysis of independent Alzheimer's
cohorts finds disruption of molecular, genetic, and clinical
networks by human Herpesvirus. Neuron. 99:64–82.e7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Swarbrick S, Wragg N, Ghosh S and Stolzing
A: Systematic review of miRNA as biomarkers in Alzheimer's disease.
Mol Neurobiol. 56:6156–6167. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sood S, Gallagher IJ, Lunnon K, Rullman E,
Keohane A, Crossland H, Phillips BE, Cederholm T, Jensen T, van
Loon LJ, et al: A novel multi-tissue RNA diagnostic of healthy
ageing relates to cognitive health status. Genome Biol. 16:1852015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang WS, Reiman EM, Valla J, Dunckley T,
Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D,
Caselli R, et al: Alzheimer's disease is associated with reduced
expression of energy metabolism genes in posterior cingulate
neurons. Proc Natl Acad Sci USA. 105:4441–4446. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng L, Doecke JD, Sharples RA,
Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay
SL, Masters CL, et al: Prognostic serum miRNA biomarkers associated
with Alzheimer's disease shows concordance with neuropsychological
and neuroimaging assessment. Mol Psychiatry. 20:1188–1196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McKeever PM, Schneider R, Taghdiri F,
Weichert A, Multani N, Brown RA, Boxer AL, Karydas A, Miller B,
Robertson J and Tartaglia MC: MicroRNA expression levels are
altered in the cerebrospinal fluid of patients with young-onset
Alzheimer's disease. Mol Neurobiol. 55:8826–8841. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan L, Yu JT, Liu QY, Tan MS, Zhang W, Hu
N, Wang YL, Sun L, Jiang T and Tan L: Circulating miR-125b as a
biomarker of Alzheimer's disease. J Neurol Sci. 336:52–56. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Galimberti D, Villa C, Fenoglio C,
Serpente M, Ghezzi L, Cioffi SM, Arighi A, Fumagalli G and Scarpini
E: Circulating miRNAs as potential biomarkers in Alzheimer's
disease. J Alzheimers Dis. 42:1261–1267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fei Y, Guo P, Wang F, Li H, Lei Y, Li W,
Xun X and Lu F: Identification of miRNA-mRNA crosstalk in laryngeal
squamous cell carcinoma. Mol Med Rep. 16:4179–4186. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lau P, Bossers K, Janky R, Salta E,
Frigerio CS, Barbash S, Rothman R, Sierksma AS, Thathiah A,
Greenberg D, et al: Alteration of the micro RNA network during the
progression of Alzheimer's disease. EMBO Mol Med. 5:1613–1634.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hara N, Kikuchi M, Miyashita A, Hatsuta H,
Saito Y, Kasuga K, Murayama S, Ikeuchi T and Kuwano R: Serum
microRNA miR-501-3p as a potential biomarker related to the
progression of Alzheimer's disease. Acta Neuropathol Commun.
5:102017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jia LH and Liu YN: Downregulated serum
miR-223 servers as biomarker in Alzheimer's disease. Cell Biochem
Funct. 34:233–237. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Qi Y, Liu CF, Lu JM, Shi J and Shi
Y: MicroRNA expression data analysis to identify key miRNAs
associated with Alzheimer's disease. J Gene Med. 20:e30142018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cătană CS, Crişan CA, Opre D and
Berindan-Neagoe I: Diagnostic and prognostic value of microRNAs for
Alzheimer's disease: A comprehensive meta-analysis. Med Pharm Rep.
93:53–61. 2020.PubMed/NCBI
|
|
17
|
Barrett T, Suzek TO, Troup DB, Wilhite SE,
Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W and Edgar R: NCBI
GEO: Mining millions of expression profiles-database and tools.
Nucl Acids Res. 33((Database Issue)): D562–D566. 2005.PubMed/NCBI
|
|
18
|
Tan L, Yu JT, Tan MS, Liu QY, Wang HF,
Zhang W, Jiang T and Tan L: Genome-Wide Serum microRNA expression
profiling identifies serum biomarkers for Alzheimer's disease. J
Alzheimers Dis. 40:1017–1027. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong H, Li J, Huang L, Chen X, Li D, Wang
T, Hu C, Xu J, Zhang C, Zen K, et al: Serum MicroRNA profiles serve
as novel biomarkers for the diagnosis of Alzheimer's disease. Dis
Markers. 2015:6256592015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu Y, Li C, Sun A, Wang Y and Zhou S:
Quantification of microRNA-210 in the cerebrospinal fluid and
serum: Implications for Alzheimer's disease. Exp Ther Med.
9:1013–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar P, Dezso Z, MacKenzie C, Oestreicher
J, Agoulnik S, Byrne M, Bernier F, Yanagimachi M, Aoshima K and Oda
Y: Circulating miRNA Biomarkers for Alzheimer's disease. PLoS One.
8:e698072013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kiko T, Nakagawa K, Tsuduki T, Furukawa K,
Arai H and Miyazawa T: MicroRNAs in plasma and cerebrospinal fluid
as potential markers for Alzheimer's disease. J Alzheimers Dis.
39:253–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang T, Chen K, Li H, Dong S, Su N, Liu Y,
Cheng Y, Dai J, Yang C and Xiao S: The feasibility of utilizing
plasma MiRNA107 and BACE1 messenger RNA gene expression for
clinical diagnosis of amnestic mild cognitive impairment. J Clin
Psychiatry. 76:135–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu CG, Wang JL, Li L and Wang PC:
MicroRNA-384 regulates both amyloid precursor protein and
β-secretase expression and is a potential biomarker for Alzheimer's
disease. Int J Mol Med. 34:160–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leidinger P, Backes C, Deutscher S,
Schmitt K, Mueller SC, Frese K, Haas J, Ruprecht K, Paul F, Stähler
C, et al: A blood based 12-miRNA signature of Alzheimer disease
patients. Genome Biol. 14:R782013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimes PK, Liu Y, Neil Hayes D and Marron
JS: Statistical significance for hierarchical clustering.
Biometrics. 73:811–821. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C,
Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0:
Service integration into miRNA functional analysis workflows.
Nucleic Acids Res. 41:W169–W173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu W and Wang X: Prediction of functional
microRNA targets by integrative modeling of microRNA binding and
target expression data. Genome Biol. 20:182019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M
and Rajewsky N: Combinatorial microRNA target predictions. Nat
Genet. 37:495–500. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
33
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takashima Y, Kawaguchi A, Iwadate Y,
Hondoh H, Fukai J, Kajiwara K, Hayano A and Yamanaka R: MicroRNA
signature constituted of miR-30d, miR-93, and miR-181b is a
promising prognostic marker in primary central nervous system
lymphoma. PLoS One. 14:e02104002019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Allen M, Cox C, Belbin O, Ma L, Bisceglio
GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, et al:
Association and heterogeneity at the GAPDH locus in Alzheimer's
disease. Neurobiol Aging. 33:203.e25–e33. 2012. View Article : Google Scholar
|
|
36
|
Butterfield DA, Hardas SS and Lange MLB:
Oxidatively modified Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and Alzheimer's disease: Many pathways to
neurodegeneration. J Alzheimers Dis. 20:369–393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang WS, Wang YH, Zhu XT and Wu CJ:
Genome-wide profiling of miRNA and mRNA expression in Alzheimer's
disease. Med Sci Monit. 23:2721–2731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mateo I, Vázquez-Higuera JL, Sánchez-Juan
P, Rodríguez- Rodríguez E, Infante J, García-Gorostiaga I, Berciano
J and Combarros O: Epistasis between tau phosphorylation regulating
genes (CDK5R1 and GSK-3beta) and Alzheimer's disease risk. Acta
Neurol Scand. 120:130–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Spreafico M, Grillo B, Rusconi F,
Battaglioli E and Venturin M: Multiple layers of CDK5R1 regulation
in Alzheimer's disease implicate long non-coding RNAs. Int J Mol
Sci. 19(pii): E20222018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Puglielli L: Aging of the brain,
neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the
common culprit? Neurobiol Aging. 29:795–811. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Karki R, Kodamullil AT and Hofmann-Apitius
M: Comorbidity Analysis between Alzheimer's disease and type 2
diabetes mellitus (T2DM) based on shared pathways and the role of
T2DM drugs. J Alzheimers Dis. 60:721–731. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jasmin B: Impairment of insulin signalling
pathway in Alzheimer´s disease. University of Wuzburg, Faculty of
Science. 1–13. 2012.
|
|
43
|
Liu Y, Liu F, Grundke-Iqbal I, Iqbal K and
Gong CX: Deficient brain insulin signalling pathway in Alzheimer's
disease and diabetes. J Pathol. 225:54–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
